Regulation & Compliance

A massive data breach at benefits firm Paylogix exposes vast sensitive data, placing individuals at risk and revealing deep vulnerabilities in the HR tech industry.

With a high-yield dividend and perfect rent collection, NewLake Capital signals stability. But is this cannabis REIT a safe haven or just a high-risk reward?

Canada's Buhler Versatile acquires German heavyweight ATLAS, rescuing the 100-year-old brand from restructuring in a bold European expansion by parent ASKO.

The Chinese insurtech's massive share consolidation is a desperate bid to stay on Nasdaq, but it reveals deeper struggles facing Chinese ADRs in the US.

Novartis unveils groundbreaking Phase III data for Rhapsido, offering hope as the first potential targeted therapy for 29 million chronic hive sufferers.

With a new CMO, Get A Drip is capitalizing on the longevity trend. But as it expands, it faces questions on scientific rigor and regulatory oversight.

Binance re-enters the tokenized stock arena with bStocks, offering 24/7 access to US equities. But what do the regulatory approvals and fine print mean?

Angliabet's reported 15% satisfaction jump from instant withdrawals signals a new era. But does this speed-driven strategy mask deeper risks for UK players?

ComplianceCow’s new AI turns plain English into auditable controls in ServiceNow, promising a GRC revolution. But can deterministic AI overcome skepticism?

After 300 races, a new era of F1 oversight begins. Marelli's AI-powered data recorder, the SDR 5, promises unprecedented insights for safety and fair play.

As enterprises grapple with record credential theft and ungoverned AI, Josys's new platform offers an autonomous shield for every identity—human and machine.

With a promising cancer therapy but precarious finances, Propanc Biopharma's stock buyback raises a critical question: is it a sign of confidence or a high-stakes gamble?

NetClass is expanding its AI language tools beyond English, but its latest partnerships reveal a more ambitious play: linking educational AI with smart healthcare.

A novel case study reveals how targeted chemotherapy delivery is outsmarting stubborn tumors, highlighting a metabolic victory even when size remains unchanged.

As global executives gather in Qingdao, the summit reveals China's new playbook: a targeted bid for high-tech MNEs to fuel its 15th Five-Year Plan.

Eightco Holdings offers a public backdoor to the AI gold rush with its OpenAI stake, but a closer look reveals a high-stakes portfolio of crypto and private equity.

Binance's spot on the Fortune Crypto 100 is a mainstream win, but it masks a deeper story of regulatory battles and a high-stakes pivot to a financial super app.

Elwood's integration with Kalshi isn't just a tech deal; it's a growth signal that prediction markets are getting the institutional rails they need to grow up.

With Thomas Winstanley at the helm, Edibles.com eyes dominance in the wellness-THC space. Can his CPG playbook conquer a booming but volatile market?

As quantitative tightening shrinks liquidity, Sweden's central bank is telling banks to test their borrowing capacity. It's a crucial fire drill for a new era.